Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province
- PMID: 32973508
- PMCID: PMC7466677
- DOI: 10.3389/fphar.2020.01267
Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province
Abstract
Introduction: The World Health Organization identified Pharmaceutical and Therapeutics Committees (PTCs) at district and hospital levels as one of the pivotal models to promote rational use of medicines (RUM). This is endorsed by the Government in South Africa. Formulary development and management is one of the main functions of PTCs. This study aimed to describe the formulary management activities among PTCs in public hospitals in Gauteng Province, South Africa, following initiatives to promote RUM in South Africa.
Methods: Qualitative, nonparticipatory, observational study, observing 26 PTC meetings. Data were coded and categorized using NVivo9® qualitative data analysis software. Themes and sub-themes were developed. The themes and sub-themes on formulary management are the principal focus of this paper.
Results: More than half of the observed PTCs reviewed their formulary lists. There was variation in the review process among institutions providing different levels of care. Various aspects were considered for formulary management especially requests for medicines to be added. These included cost considerations (mainly focusing on acquisition costs), evidence-based evaluation of clinical trials, patient safety, clinical experience and changes in the National Essential Medicines List (NEML). The tertiary PTCs mostly dealt with applications for new non-EML medicines, while PTCs in the other hospitals mainly requested removal or addition of EML medicines to the list.
Conclusion: This is the first study from Gauteng Province, South Africa, reporting on how decisions are actually taken to include or exclude medicines onto formularies within public sector hospitals providing different levels of care. Various approaches are adopted at different levels of care when adding to- or removing medicines from the formulary lists. Future programs should strengthen PTCs in specialized aspects of formulary management. A more structured approach to formulary review at the local PTC level should be encouraged in line with the national approach when reviewing possible additions to the NEML.
Keywords: South Africa; essential medicines; formulary; list (data structure); management; pharmaceutical and therapeutics committees; rational medicine use.
Copyright © 2020 Matlala, Gous, Meyer and Godman.
Figures
Similar articles
-
Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.Expert Rev Clin Pharmacol. 2017 Nov;10(11):1273-1280. doi: 10.1080/17512433.2017.1364625. Epub 2017 Aug 16. Expert Rev Clin Pharmacol. 2017. PMID: 28776442
-
Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals.Expert Rev Clin Pharmacol. 2019 Feb;12(2):159-168. doi: 10.1080/17512433.2018.1545572. Epub 2018 Nov 19. Expert Rev Clin Pharmacol. 2019. PMID: 30407089
-
Selection of medicines in Chilean public hospitals: an exploratory study.BMC Health Serv Res. 2013 Jan 7;13:10. doi: 10.1186/1472-6963-13-10. BMC Health Serv Res. 2013. PMID: 23294543 Free PMC article.
-
The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.Drug Saf. 1998 Mar;18(3):153-9. doi: 10.2165/00002018-199818030-00001. Drug Saf. 1998. PMID: 9530535 Review.
-
Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.J Clin Pharm Ther. 2020 Apr;45(2):249-255. doi: 10.1111/jcpt.13067. Epub 2019 Oct 27. J Clin Pharm Ther. 2020. PMID: 31657022 Review.
Cited by
-
Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future.Antibiotics (Basel). 2022 Dec 15;11(12):1824. doi: 10.3390/antibiotics11121824. Antibiotics (Basel). 2022. PMID: 36551481 Free PMC article.
-
Patient safety culture at the unit level of a tertiary hospital in South Africa: a survey study.J Public Health Afr. 2023 Apr 28;14(5):2228. doi: 10.4081/jphia.2023.2228. eCollection 2023 Apr 30. J Public Health Afr. 2023. PMID: 37404332 Free PMC article.
-
A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list.Pediatr Rheumatol Online J. 2024 Jul 4;22(1):63. doi: 10.1186/s12969-024-00997-x. Pediatr Rheumatol Online J. 2024. PMID: 38965620 Free PMC article.
-
Attitude and perception of pharmacists and healthcare professionals about the criteria used in drug formulary selection in the United Arab Emirates.J Pharm Policy Pract. 2022 Oct 18;15(1):67. doi: 10.1186/s40545-022-00460-w. J Pharm Policy Pract. 2022. PMID: 36258258 Free PMC article.
-
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries.Life (Basel). 2021 Jun 7;11(6):528. doi: 10.3390/life11060528. Life (Basel). 2021. PMID: 34200116 Free PMC article. Review.
References
-
- Abdelrahim S. B., Shaddad S. A., Kheder S. (2012). ssessment of Structure, Implementation and Activities, Hospital Formulary System in Khartoum State Hospitals. J. Pharm. Biomed. Sci. 22 (23), 1–6.
-
- Anand Paramadhas B. D., Tiroyakgosi C., Mpinda-Joseph P., Morokotso M., Matome M., Sinkala F., et al. (2019). Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications. Expert Rev. Anti-infective Ther. 17 (7), 535–546. 10.1080/14787210.2019.1629288 - DOI - PubMed
-
- Attaei M. W., Khatib R., McKee M., Lear S., Dagenais G., Igumbor E. U., et al. (2017). Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet Public Health 2 (9), e411–e4e9. 10.1016/S2468-2667(17)30141-X - DOI - PubMed
LinkOut - more resources
Full Text Sources